Evidence map›Paper›PMID 36619198›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Anthocyanins from

Hongli Fan, Yonggan Ji, Yang Wang, Danni Liu, Tingting Wei, Xue Cao, Mengmeng Yang, Changcai Bai, Zhisheng Wang

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hongli FanSchool of Pharmacy, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China.ORCID https://orcid.org/0000-0002-8529-9894
Yonggan JiSchool of Pharmacy, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China.ORCID https://orcid.org/0000-0003-1882-2136
Yang WangThe Third Clinical College, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China.ORCID https://orcid.org/0000-0002-7001-1149
Danni LiuThe Third Clinical College, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China.ORCID https://orcid.org/0000-0002-6044-7547
Tingting WeiCancer Hospital, Ningxia Medical University General Hospital, Yinchuan 750004, Ningxia Hui Autonomous Region, China.ORCID https://orcid.org/0000-0001-5386-2577
Xue CaoCancer Hospital, Ningxia Medical University General Hospital, Yinchuan 750004, Ningxia Hui Autonomous Region, China.ORCID https://orcid.org/0000-0002-1640-8209
Mengmeng YangLaboratory Animal Center, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China.ORCID https://orcid.org/0000-0003-1210-4424
Changcai BaiSchool of Pharmacy, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China.ORCID https://orcid.org/0000-0001-8321-559X
Zhisheng WangSchool of Pharmacy, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China.ORCID https://orcid.org/0000-0003-3795-9007
Ningxia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the most common malignancies in humans, liver cancer ranks third in terms of mortality in the world. Seeking new anticancer drugs or adjuvant chemotherapy drugs from natural products has attracted the attention of many researchers.

Identifiers

PMID36619198
PMCPMC9822762
OpenAlexW4313364857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.